The people
What they build
Open roles via the TechTO Job Board
Working at Rapid Novor
Browse open roles across the community on the TechTO Job Board — Canada’s most connected tech network. Rapid Novor’s roles show up here whenever they post.
Open roles on the TechTO Job Board ↗Or their own careers page: rapidnovor.com/careers ↗Jobs live on jobs.techto.org — the only structured source. We link to it rather than scraping career sites, so the board is always the source of truth.
On the TechTO stage
Every talk is searchable — ask the archive about Rapid Novor ↗
About
Founded around 2015 by University of Waterloo mathematics professor Dr. Bin Ma, Rapid Novor grew out of his earlier company Bioinformatics Solutions. It funds its research largely through contract protein-sequencing work, alongside a US$5M Series A led by Co-Win Venture announced in July 2020. As of its 2018 TechTO HealthTO talk the team was about 13 people; it has since built products such as EasyM for monitoring M-protein in multiple myeloma patients.
Backers
US$5M Series A led by Co-Win Venture (announced July 2020), alongside contract research revenue
Quick answers
What does Rapid Novor do?
It sequences antibodies directly from the protein itself — similar to DNA sequencing but without needing the DNA — as a contract service for pharma and research clients, and develops its own diagnostic products.
Who founded Rapid Novor?
Dr. Bin Ma, a tenured mathematics professor at the University of Waterloo who had previously founded Bioinformatics Solutions, co-founded it with Mingjie Xie (CEO) and Qixin Liu (CTO), per the company's About page.